The generative AI boom is getting a little long in the tooth.2025 has been a banner year for Nvidia (NVDA +3.80%) investors. Shares in the AI hardware titan have soared by 32% this year, trouncing the S&P 500's comparatively measly return of just 15%. That said, the generative artificial intelligence (AI) hardware boom is getting long in the tooth, leaving investors wondering if Nvidia can maintain its momentum in 2026. Let's dig deeper to see what the future may bring for the stock. Nvidia is still a fanta ...

The author has an honours degree in economics and politics with a focus on economic development. With 36 years of experience in executive management he has extensive knowledge of insurance/reinsurance, Global and Asia Pacific markets, climate change and ESG. He invests in his personal capacity.Analyst’s Disclosure:I/we have a beneficial long position in the shares of LGGNY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not r ...

Thank you, Kelly and Jason. Thank you for joining us today. First off, set the expectation for investors.How meaningful will this be for DraftKings bottom line. >> Well, I think at least initially we don't know. It's a new product and um I do think that it will eventually be meaningful for the bottom line, but right now it just launched.So, uh it's first day and we're getting some data, so hard to to say what exactly it will do. >> All right, we'll come back to you at the end of the day. No, I'm just kiddin ...

The author has an honours degree in economics and politics with a focus on economic development. With 36 years of experience in executive management he has extensive knowledge of insurance/reinsurance, Global and Asia Pacific markets, climate change and ESG. He invests in his personal capacity.Analyst’s Disclosure:I/we have a beneficial long position in the shares of LGGNY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not r ...

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

US stocks displayed resilience on Friday as Nvidia and other AI-focused semiconductor names powered a tech-led rebound, sending the Nasdaq Composite higher while the S&P 500 and Dow Jones also advance... ...

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CarMax, Inc. (NYSE: KMX) between June 20, 2025 and November 5, 2025, both dates inclusive (the “Class Period”) of the important January 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased CarMax securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or co ...

Rivian grew sales nicely in Q3, but growing sales in 2026 could be harder -- even with a new electric SUV to sell.For the second day in a row, shares of Rivian Automotive (RIVN +8.41%) stock climbed higher Friday -- up 10.5% through 2:20 p.m. ET -- and for the same reason as yesterday:A Wall Street analyst is raising its price target on Rivian. Why Wall Street loves RivianYesterday, Baird analyst Ben Kallo raised his price target on Rivian stock from $14 to $25. Kallo cited Rivian's upcoming introduction of ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans. ...